PeptiDream Inc. (PPTDF)
OTCMKTS
· Delayed Price · Currency is USD
13.53
0.00 (0.00%)
May 20, 2025, 4:00 PM EDT
PeptiDream Revenue
PeptiDream had revenue of 4.23B JPY in the quarter ending March 31, 2025, with 0.19% growth. This brings the company's revenue in the last twelve months to 46.68B, up 66.88% year-over-year. In the year 2024, PeptiDream had annual revenue of 46.68B with 62.57% growth.
Revenue (ttm)
46.68B JPY
Revenue Growth
+66.88%
P/S Ratio
4.92
Revenue / Employee
75.18M JPY
Employees
621
Market Cap
1.53B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |